Bipolar Disorder clinical trials
- Phase
- Phase 2/3
- Phase
- Phase 3
- Phase
- Not Applicable
Access comprehensive clinical trial information for Bipolar Disorder through Pure Global AI's free database. This collection includes 479 clinical trials across multiple phases including N/A, Phase 3, Phase 4. Currently, 52 trials are actively recruiting participants.
Research for Bipolar Disorder is being conducted in United States of America, Canada, China and 7+ other countries. Leading sponsors include National Institute of Mental Health (NIMH) and AstraZeneca. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Pure Global AI provides free access to 479 clinical trials studying Bipolar Disorder, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include National Institute of Mental Health (NIMH), AstraZeneca, GlaxoSmithKline, among others.